Shin-ichiro Hattori

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 15 papers. Top paper: “Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma”.

Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma

Scientific Reports(2021)10.1038/s41598-021-84733-5

N/A

1.6DataRank · unranked

54 citations

Nobuyo Higashi-Kuwata, Noriko Kinoshita, Satoshi Kutsuna, Kiyoto Tsuchiya, Shin-ichiro Hattori +8 more

GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection

mBio(2020)10.1128/mbio.01833-20

N/A

0DataRank · unranked

79 citations

Nobuyo Higshi-Kuwata, Jakka Raghavaiah, Debananda Das, Haydar Bulut, David A. Davis +11 more

Identification of a novel long-acting 4’-modified nucleoside reverse transcriptase inhibitor against HBV

Journal of Hepatology(2020)10.1016/j.jhep.2020.12.006

N/A

0DataRank · unranked

28 citations

Sanae Hayashi, Hiroki Kumamoto, Hiromi Ogata-Aoki, Debananda Das, David Venzon +12 more

7-Deaza-7-fluoro modification confers on 4′-cyano-nucleosides potent activity against entecavir/adefovir-resistant HBV variants and favorable safety

Antiviral Research(2020)10.1016/j.antiviral.2020.104744

N/A

0DataRank · unranked

7 citations

Nobuyo Higashi‐Kuwata, Debananda Das, Kota Tomaya, Kohei Yamada, Shuko Murakami +7 more

A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication

Nature Communications(2021)10.1038/s41467-021-20900-6

N/A

0DataRank · unranked

196 citations

Nobuyo Higashi‐Kuwata, Hironori Hayashi, Srinivasa Rao Allu, Jakka Raghavaiah, Haydar Bulut +18 more

Characterization of a new SARS-CoV-2 variant that emerged in Brazil

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2106535118

N/A

0DataRank · unranked

87 citations

Peter Halfmann, Seiya Yamayoshi, Kiyoko Iwatsuki‐Horimoto, S. Chiba, Tokiko Watanabe +54 more

Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors

Molecules(2021)10.3390/molecules26195782

N/A

0DataRank · unranked

14 citations

Dana Shahabi, Monika Yadav, Satish Kovela, Brandon J. Anson, Emma K. Lendy +8 more

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

Nature(2022)10.1038/s41586-022-04856-1

N/A

0DataRank · unranked

293 citations

Maki Kiso, Shun Iida, Masaki Imai, Emi Takashita, Makoto Kuroda +64 more

Design, Synthesis and X‐Ray Structural Studies of Potent HIV‐1 Protease Inhibitors Containing C‐4 Substituted Tricyclic Hexahydro‐Furofuran Derivatives as P2 Ligands

ChemMedChem(2022)10.1002/cmdc.202200058

N/A

0DataRank · unranked

6 citations

Satish Kovela, Ashish Sharma, Dana Shahabi, Ajay K. Ghosh, Denver R. Hopkins +11 more

Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2

Nature Communications(2023)10.1038/s41467-023-36729-0

N/A

0DataRank · unranked

45 citations

Kohei Tsuji, Hironori Hayashi, Haydar Bulut, Maki Kiso, Masaki Imai +30 more

SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads

Bioorganic & Medicinal Chemistry Letters(2023)10.1016/j.bmcl.2023.129489

N/A

0DataRank · unranked

12 citations

Dana Shahabi, Mackenzie E.C. Imhoff, Satish Kovela, Ashish Sharma, Shin-ichiro Hattori +4 more

Exploration of imatinib and nilotinib-derived templates as the P2-Ligand for HIV-1 protease inhibitors: Design, synthesis, protein X-ray structural studies, and biological evaluation

European Journal of Medicinal Chemistry(2023)10.1016/j.ejmech.2023.115385

N/A

0DataRank · unranked

5 citations

Jennifer L. Mishevich, Satish Kovela, Ryan Shaktah, Ajay K. Ghosh, Megan Johnson +9 more

Structural and virologic mechanism of the emergence of resistance to M pro inhibitors in SARS-CoV-2

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2404175121

N/A

0DataRank · unranked

15 citations

Haydar Bulut, Hironori Hayashi, Naoki Kishimoto, Nobutoki Takamune, Kazuya Hasegawa +10 more

An orally available P1′-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier

PNAS Nexus(2024)10.1093/pnasnexus/pgae578

N/A

0DataRank · unranked

9 citations

Haydar Bulut, Hironori Hayashi, Kohei Tsuji, Hiromi Ogata-Aoki, Maki Kiso +23 more

Tecovirimat is active against various MPXV strains, while cidofovir, brincidofovir, trifluridine, and gemcitabine have no detectable MPXV-specific antiviral activity

Virus Research(2025)10.1016/j.virusres.2025.199615

N/A

0DataRank · unranked

3 citations

Mariko Kato, Shin-ichiro Hattori, Yuki Takamatsu, Hiroaki Mitsuya, Nobuyo Higashi‐Kuwata